The Role of Aberrant Promoter Methylation in Chronic Liver Patients and Hepatocellular Carcinoma Patients
Fatma El-Zahraa Aly Sayed;
Abstract
Abstract
Hepatocellular carcinoma (HCC) is one of the few tumors in which the incidence is on the rise worldwide. The increasing incidence of HCC is associated with the rise in hepatitis C virus (HCV) infection. Egypt has the highest prevalence of HCV/ge
Hepatocellular carcinoma (HCC) is one of the few tumors in which the incidence is on the rise worldwide. The increasing incidence of HCC is associated with the rise in hepatitis C virus (HCV) infection. Egypt has the highest prevalence of HCV/ge
Other data
| Title | The Role of Aberrant Promoter Methylation in Chronic Liver Patients and Hepatocellular Carcinoma Patients | Other Titles | دور ميثلــة البـادئ الضــال في مرضي الالتـهاب الكبـدي المـزمن و ســـرطان الكبـــد | Authors | Fatma El-Zahraa Aly Sayed | Keywords | The Role of Aberrant Promoter Methylation in Chronic Liver Patients and Hepatocellular Carcinoma Patients | Issue Date | 2013 | Description | Abstract Hepatocellular carcinoma (HCC) is one of the few tumors in which the incidence is on the rise worldwide. The increasing incidence of HCC is associated with the rise in hepatitis C virus (HCV) infection. Egypt has the highest prevalence of HCV/ge |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 120876g1339.pdf | 522.71 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.